臨床研究管理センター

Keyphrases

1. Islet 100%
2. Islet Transplantation 99%
3. Islet Isolation 70%
4. Type 1 Diabetes Mellitus (T1DM) 60%
5. Pancreas 53%
6. Type I Diabetes 41%
7. Islet Yield 31%
8. Secretory System 28%
9. Islet Purification 25%
10. Chronic Pancreatitis 24%
11. Ductal Injection 23%
12. High Mobility Group Box 1 (HMGB1) 21%
13. Human Islets 20%
14. Japanese Patients 19%
15. Isolated Islets 19%
16. Insulin 19%
17. Insulin Independence 18%
18. Collagenase 18%
19. Pancreas Preservation 16%
20. Nicotinamide Adenine Dinucleotide (NAD+) 16%
21. Type 2 Diabetic Patients 16%
22. Human Pancreas 15%
23. Transplantation 14%
24. Density Gradient 13%
25. Metabolism 13%
26. Pancreatic Cells 13%
27. Iodixanol 13%
28. Fulminant Type 1 Diabetes 13%
29. Insulin Therapy 12%
30. Hypoxia 12%
31. Insulin-producing Cells 12%
32. Porcine Islets 12%
33. Purification Process 11%
34. Allogeneic Islet Transplantation 11%
35. Islet Graft Function 11%
36. Insulin Administration 10%
37. A1 Receptor 10%
38. Glucagon-like 10%
39. Type 1 Diabetes Patients 10%
40. Area under the Curve 10%
41. Treg 10%
42. Human Fetal Liver 10%
43. Oncostatin M 10%
44. Human Pancreatic Progenitor Cells 10%
45. Fetal Liver Cells 10%
46. Vacuole 10%
47. Diffusion Magnetic Resonance Imaging (dMRI) 10%
48. Pancreatic Islet Isolation 10%
49. Osmolality 10%
50. C-Jun N-terminal Kinase 10%
51. Body Mass Index 10%
52. Hemoglobin A1c (HbA1c) 10%
53. Glutamic Acid Decarboxylase 65 (GAD65) 10%
54. Clinical Managers 9%
55. Edmonton Protocol 9%
56. Diabetes 9%
57. Digestion 9%
58. Pancreatic Ductal 9%
59. Type 2 Diabetes Mellitus (T2DM) 9%
60. C-peptide Immunoreactivity 9%
61. Maturity-onset Diabetes of the Young type 5 9%
62. Pancreatic Stem Cells 9%
63. Recovery Rate 8%
64. C-peptide 8%
65. Clinical Course 8%
66. Mouse Islets 8%
67. Cell Function 8%
68. Islet Equivalent 8%
69. Liraglutide 8%
70. Serum Levels 8%
71. Kyoto 8%
72. University Hospital 8%
73. Aging 8%
74. Braille 8%
75. Pancreatitis 8%
76. Islet Autotransplantation 7%
77. Tacrolimus 7%
78. Clinical Outcomes 7%
79. Nicotinamide 7%
80. Antigen-specific CD4 T Cells 7%
81. Diabetic Patients 7%
82. CD4+ T Cells 7%
83. Stem Progenitor Cells 7%
84. Human Embryonic Stem Cells (hESCs) 7%
85. Stem Cell Lines 7%
86. Clinical Characteristics 7%
87. Diabetic Ketoacidosis 7%
88. Adverse Events 7%
89. Porcine Pancreas 7%
90. Islet Culture 7%
91. Brain-dead Donor 7%
92. Clinical Trials 7%
93. Dryness 6%
94. Tissue Volume 6%
95. HLA Class II 6%
96. Insulin Gene 6%
97. Genotype 6%
98. Culture Media 6%
99. High Risk 6%
100. Metabolic Syndrome 6%

Medicine and Dentistry

1. Islet Transplantation 77%
2. Insulin Dependent Diabetes Mellitus 41%
3. Diabetes 27%
4. Diabetes Mellitus 27%
5. Copurification 27%
6. Transplantation 25%
7. Collagenase 25%
8. Chronic Pancreatitis 24%
9. Islet Cell Transplantation 22%
10. Maturity Onset Diabetes of the Young 19%
11. Autotransplantation 16%
12. C-Peptide 15%
13. Hypoxia 14%
14. Fulminant 13%
15. Insulin Release 13%
16. Blood Glucose 13%
17. Hemoglobin A1c 12%
18. Pancreatectomy 12%
19. Viaspan 11%
20. Infusion 11%
21. Edmonton Protocol 11%
22. Iodixanol 11%
23. Programmed Cell Death 11%
24. Glycemic 11%
25. Diffusion MRI 10%
26. Oncostatin M 10%
27. Dexamethasone 10%
28. Liver Cell 10%
29. Vacuolization 10%
30. Progenitor Cell 10%
31. Pancreatic Islet 10%
32. Body Mass Index 10%
33. Body Weight 10%
34. Trypsin Inhibitor 10%
35. Hypoglycemia 9%
36. Messenger RNA 9%
37. Autoimmunity 9%
38. Cell Function 9%
39. Adverse Event 8%
40. Liraglutide 8%
41. T Cell 8%
42. Phosphotransferase 8%
43. Blood Glucose Monitoring 8%
44. Acupuncture 8%
45. Pregnancy 7%
46. Tacrolimus 7%
47. Pancreatitis 7%
48. Immunoreactivity 7%
49. Immunosuppressive Treatment 7%
50. Provocation Test 7%
51. Endocrine Function 7%
52. Stem Cell Line 7%
53. Human Embryonic Stem Cell 7%
54. High Mobility Group B1 Protein 7%
55. Antigen Specificity 7%
56. Glucagon 7%
57. Graft Dysfunction 7%
58. Diabetic Ketoacidosis 6%
59. Xerostomia 6%
60. Prevalence 6%
61. Disease Course 6%
62. Glucagon-Like Peptide-1 Agonist 6%
63. Interleukin 6 6%
64. Preservation Solution 6%
65. Antidiabetic Agent 6%
66. Peripheral Blood Mononuclear Cell 6%
67. Enzyme Linked Immunosorbent Assay 6%
68. Anakinra 6%
69. Cell Damage 6%
70. Nesidioblastosis 6%
71. Mouth 6%
72. In Vitro 6%
73. Anti-Inflammatory Drug 5%
74. Disease 5%
75. Skeletal Muscle 5%
76. Gene Expression 5%
77. Epithelial Cell 5%
78. Insulin Treatment 5%
79. Electrocardiography 5%
80. Patient with Type 2 Diabetes 5%
81. Self Monitoring 5%
82. Tumor Necrosis Factor 5%
83. Insulin Sensitivity 5%
84. Nephropathy 5%
85. Coitus 5%
86. Dendritic Cell 5%
87. Glucagon Like Peptide 1 Receptor 5%
88. Base Excision Repair 5%
89. Spontaneous Abortion 5%
90. Spontaneous Pneumothorax 5%
91. Thymocyte Antibody 5%
92. Proliferative Retinopathy 5%
93. Glycyrrhiza Uralensis Root 5%
94. Patient with Diabetes 5%
95. T-Helper Cell 5%
96. Clinical Research 5%
97. Hepatocyte Nuclear Factor 1beta 5%
98. Phosphotransferase Inhibitor 5%
99. Acinar Cell 5%
100. Hypertriglyceridemia 5%